retatrutide clinical trials results weight loss fat trial Retatrutide, an Amazing Future for This data from Phase 3 – Eli Lilly infiltrates anti-obesity market

What This Means for Patients In the era of GLP-1s: Many patients who once would have gone straight to surgery no longer need it Surgery is more targeted and intentional Personalized care matters more than ever The best plan depends on: Your weight and metabolic health Presence of diabetes or other conditions Past weight-loss attempts Medication tolerance Long-term goals and preferences The Bottom Line GLP-1 medications havent replaced gastric bypass theyve refined its role

10.1016/j.neuint.2011.11.009 79 PaulB

GLP-1 users rapidly evolving tastes and behaviors are drawing heightened attention across the food and beverage landscape

The secondary efficacy endpoints were the change in the Fibromyalgia Impact QuestionnaireRevised (FIQ-R, Italian version) score, in the Short Form 12 (SF12) score and in the Pittsburgh Sleep Quality Index (PSQI) score from baseline to the end of the observation period

Biochemistry 29 , 56475659 (1990)

Disrupted cortisol patterns help explain many of the symptoms long COVID patients consistently report, including: Fatigue Sleep dysfunction Inflammatory amplification Poor stress resilience Gut Microbiome Disruption COVID-19 causes significant gut microbiome disruption during acute infection, and research shows this disruption can persist for months in long COVID patients